CARL · CARLSMED INC
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Market Cap
389.6M
52 Wk Range
$8.50 - $17.23
Previous Close
$13.76
Open
$13.97
Volume
151,651
Day Range
$13.70 - $14.61
Enterprise Value
336.2M
Cash
89.22M
Avg Qtr Burn
-7.358M
Insider Ownership
45.04%
Institutional Own.
40.38%
Qtr Updated
Jun 30th 2026
